[HTML][HTML] Management guidelines for children with thyroid nodules and differentiated thyroid cancer

L FrancisGary, G WaguespackSteven, J BauerAndrew… - Thyroid, 2015 - liebertpub.com
Background: Previous guidelines for the management of thyroid nodules and cancers were
geared toward adults. Compared with thyroid neoplasms in adults, however, those in the …

Pediatric thyroid cancer: genetics, therapeutics and outcome

AJ Bauer - Endocrinology and Metabolism Clinics, 2020 - endo.theclinics.com
Most patients with thyroid cancer are asymptomatic at the time of diagnosis even in the
presence of regional or distant metastasis. More than 85% of childhood thyroid carcinomas …

Dose–response relationship in differentiated thyroid cancer patients undergoing radioiodine treatment assessed by means of 124I PET/CT

R Wierts, B Brans, B Havekes… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The dose–response relationship in a fixed-activity approach generally applied in the
treatment of differentiated thyroid cancer was assessed using 124I PET/CT. Methods …

Pediatric papillary thyroid cancer: current management challenges

FA Verburg, HM Van Santen, M Luster - OncoTargets and therapy, 2016 - Taylor & Francis
Although with a standardized incidence of 0.54 cases per 100,000 persons, differentiated
thyroid cancer (DTC) is a rare disease in children and adolescents, it nonetheless …

The NUKDOS software for treatment planning in molecular radiotherapy

P Kletting, S Schimmel, H Haenscheid, M Luster… - … für Medizinische Physik, 2015 - Elsevier
The aim of this work was the development of a software tool for treatment planning prior to
molecular radiotherapy, which comprises all functionality to objectively determine the activity …

Radioactive iodine therapy

SL Lee - Current Opinion in Endocrinology, Diabetes and …, 2012 - journals.lww.com
RAI is a common tool for the endocrinologist in the management of hyperthyroidism and
differentiated thyroid cancer. Review of the management decisions and practice of RAI …

Differentiated thyroid cancer—personalized therapies to prevent overtreatment

M Luster, T Weber, FA Verburg - Nature Reviews Endocrinology, 2014 - nature.com
The concept of individualized therapy is rapidly gaining recognition in the management of
patients with differentiated thyroid cancer (DTC). This Review provides an overview of the …

Bone-marrow suppression in elderly patients following empiric radioiodine therapy: real-life data

H Duskin-Bitan, A Leibner, O Amitai, T Diker-Cohen… - Thyroid, 2019 - liebertpub.com
Background: Elderly patients with differentiated thyroid cancer (DTC) tend to have more
advanced disease at presentation, for which high activities of radioiodine (RAI) are often …

Ten year experience of radioiodine dosimetry: is it useful in the management of metastatic differentiated thyroid cancer?

F Sun, GE Gerrard, JK Roberts, T Telford, S Namini… - Clinical Oncology, 2017 - Elsevier
Aims When a fixed activity of radioiodine is given for differentiated thyroid cancer (DTC),
absorbed doses of radioiodine can vary widely and are not usually measured. Leeds …

Thyroid cancer in pediatrics

J Machac - Endocrinology and Metabolism Clinics, 2016 - endo.theclinics.com
Traditionally, the management of differentiated thyroid cancer (DTC) in children was
approached similarly to adults. There has been a scarcity of published experience and …